Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH

Completed

Conditions studied: Subarachnoid Hemorrhage, Intracerebral Hemorrhage

In brief

The purpose of this research is to explore ways to improve and simplify control of blood pressure in patients with SAH or ICH. This research will be done by comparing tow different medications that are routinely used to help control blood pressure. None of the medications used in this study nor any procedures performed are experimental.

Key facts

Study ID

NCT00490464

Run by

University of Illinois at Chicago

People needed

163

Starts

2004-06-01

Expected to finish

2007-02-01

Last updated by the study team

2007-06-22

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18-70 years old (inclusive)
• Admission to NSICU with a diagnosis of SAH or ICH

You may not qualify if…

• Patients who are admitted >48 hours after SAH or ICH
• Readmission or second SAH
• Readmission or second ICH
• Large (immediately life threatening) associated intraparenchymal or intraventricular hemorrhage
• Women who are pregnant

Where it is running

• University of Illinois at Chicago, UIC — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.